Skip to main content
Top
Published in: AIDS and Behavior 6/2013

01-07-2013 | Brief Report

HIV-Negative and HIV-Positive Gay Men’s Attitudes to Medicines, HIV Treatments and Antiretroviral-based Prevention

Authors: Martin Holt, Dean Murphy, Denton Callander, Jeanne Ellard, Marsha Rosengarten, Susan Kippax, John de Wit

Published in: AIDS and Behavior | Issue 6/2013

Login to get access

Abstract

We assessed attitudes to medicines, HIV treatments and antiretroviral-based prevention in a national, online survey of 1,041 Australian gay men (88.3 % HIV-negative and 11.7 % HIV-positive). Multivariate analysis of variance was used to identify the effect of HIV status on attitudes. HIV-negative men disagreed with the idea that HIV drugs should be restricted to HIV-positive people. HIV-positive men agreed and HIV-negative men disagreed that taking HIV treatments was straightforward and HIV-negative men were more sceptical about whether HIV treatment or an undetectable viral load prevented HIV transmission. HIV-negative and HIV-positive men had similar attitudes to pre-exposure prophylaxis but divergent views about ‘treatment as prevention’.
Literature
1.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef
2.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.PubMedCrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.PubMedCrossRef
3.
4.
go back to reference Editorial. HIV treatment as prevention—it works. Lancet. 2011;377(9779):1719. Editorial. HIV treatment as prevention—it works. Lancet. 2011;377(9779):1719.
5.
go back to reference Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2.PubMedCrossRef Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2.PubMedCrossRef
6.
go back to reference Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention and social science. Lancet. 2007;370(9581):10–1.PubMedCrossRef Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention and social science. Lancet. 2007;370(9581):10–1.PubMedCrossRef
7.
go back to reference Editorial. Treatment as prevention for HIV. Lancet Infect Dis. 2011;11(9):651. Editorial. Treatment as prevention for HIV. Lancet Infect Dis. 2011;11(9):651.
8.
go back to reference van de Laar MJ, Pharris A. Treatment as prevention: will it work? Euro Surveill. 2011;16(48):2–4. van de Laar MJ, Pharris A. Treatment as prevention: will it work? Euro Surveill. 2011;16(48):2–4.
9.
go back to reference Holt M, Murphy DA, Callander D, Ellard J, Rosengarten M, Kippax SC, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88:258–63.PubMedCrossRef Holt M, Murphy DA, Callander D, Ellard J, Rosengarten M, Kippax SC, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88:258–63.PubMedCrossRef
10.
go back to reference Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism–scepticism in the context of HIV treatments. AIDS Care. 2000;12(2):171–6.PubMedCrossRef Van de Ven P, Crawford J, Kippax S, Knox S, Prestage G. A scale of optimism–scepticism in the context of HIV treatments. AIDS Care. 2000;12(2):171–6.PubMedCrossRef
11.
go back to reference Holt M, Mao L, Prestage G, Zablotska I, De Wit J. Gay Community Periodic Surveys: National Report 2010. Sydney: National Centre in HIV Social Research, The University of New South Wales; 2011. Holt M, Mao L, Prestage G, Zablotska I, De Wit J. Gay Community Periodic Surveys: National Report 2010. Sydney: National Centre in HIV Social Research, The University of New South Wales; 2011.
12.
go back to reference Australasian Society for HIV Medicine. HHS guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (March 28, 2012) with Australian commentary. Sydney: Australasian Society for HIV Medicine; 2012. Australasian Society for HIV Medicine. HHS guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (March 28, 2012) with Australian commentary. Sydney: Australasian Society for HIV Medicine; 2012.
Metadata
Title
HIV-Negative and HIV-Positive Gay Men’s Attitudes to Medicines, HIV Treatments and Antiretroviral-based Prevention
Authors
Martin Holt
Dean Murphy
Denton Callander
Jeanne Ellard
Marsha Rosengarten
Susan Kippax
John de Wit
Publication date
01-07-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0313-z

Other articles of this Issue 6/2013

AIDS and Behavior 6/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.